Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does total iron-binding capacity reflect transferrin produced by the liver?

TIBC functions as a practical surrogate for serum transferrin concentration, which is primarily synthesized by the liver.

PlausibleJune 19, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Total iron-binding capacity largely reflects the concentration of transferrin, a protein synthesized by the liver.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that TIBC largely reflects the amount of transferrin in blood and that transferrin is produced by hepatocytes. The mechanism frames this relationship by linking hepatic regulation of transferrin synthesis to circulating iron‑binding capacity, so changes in liver production alter TIBC measurements.

Verified conclusion

The relationship between Total Iron-Binding Capacity (TIBC) and transferrin is a fundamental principle of iron metabolism, as TIBC serves as a functional surrogate for the concentration of this liver-derived protein.

Clinical and Physiological Evidence

TIBC is a measurement of the maximum amount of iron that can be bound by serum proteins. Because transferrin is the primary iron-transport protein in the blood, it accounts for nearly all circulating iron-binding capacity under physiological conditions.

  • Correlation and Concordance: Research shows an extremely high correlation between TIBC and serum transferrin levels, often with Pearson correlation coefficients (r) exceeding 0.9.
  • Mathematical Modeling: The two markers are so linearly related that TIBC is frequently calculated directly from transferrin using a standardized conversion factor (TIBC in µg/dL ≈ transferrin in mg/dL × 1.25). This reflects the fact that each transferrin molecule contains two high-affinity binding sites for ferric iron (Fe3+).
  • Diagnostic Redundancy: Because TIBC directly reflects the transferrin pool, clinical guidelines often consider measuring both redundant, as they provide nearly identical information regarding a patient's iron status.

Mechanistic Insights into Synthesis

Transferrin is a 76 kDa glycoprotein primarily synthesized within the hepatocytes of the liver.

  • Hepatic Production: Synthesis occurs in the endoplasmic reticulum and Golgi apparatus of hepatocytes, regulated by specific transcription factors such as hepatocyte nuclear factor 4 alpha (HNF4α).
  • Regulation Mechanisms: As a negative acute-phase reactant, the liver downregulates transferrin synthesis in response to inflammatory cytokines like IL-6. Conversely, synthesis is upregulated by the liver during states of iron deficiency to maximize iron transport capacity.
  • Clinical Implications: Because the liver is the dominant source of systemic transferrin, serum levels (and consequently TIBC) are highly sensitive to hepatic synthetic function. Decreased levels are a validated indicator of hepatocyte dysfunction or chronic liver disease.

Bottom line

TIBC is a direct functional reflection of serum transferrin levels, a protein primarily synthesized by the liver. The two markers are highly concordant and serve as reliable indicators of both systemic iron homeostasis and hepatic synthetic capacity.

References

  1. Stimulatory effect of 1,25-dihydroxyvitamin D3 on transferrin synthesis in primary cultures of adult rat hepatocytes. — semanticscholar.org ↗
  2. Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases — pmc.ncbi.nlm.nih.gov ↗
  3. Sites of formation of the serum proteins transferrin and hemopexin. — pmc.ncbi.nlm.nih.gov ↗
  4. Acute Phase Reactants as Novel Predictors of Cardiovascular Disease — pmc.ncbi.nlm.nih.gov ↗
  5. The relation between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum. — academic.oup.com ↗
  6. Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity. — academic.oup.com ↗
  7. Immunochemical determination of serum transferrin. Reference values, correlation with serum total iron-binding capacity and value in the diagnosis of iron deficiency anaemia and anaemia of chronic disorders. — onlinelibrary.wiley.com ↗
  8. Is total iron binding capacity (TIBC) calculation correct? — linkinghub.elsevier.com ↗
  9. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. — escholarship.org ↗
  10. Iron studies and transferrin, a source of test ordering confusion highly amenable to clinical decision support. — linkinghub.elsevier.com ↗
  11. Appropriate Method of TIBC Estimation in Reference to Serum Transferrin Levels — jlabphy.org ↗
  12. Appropriate Method of TIBC Estimation in Reference to Serum Transferrin Levels — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→